Our Board of Directors
Robert Koffman, MD, MPHBoard Chair
Retired US Naval Officer
Robert (Bob) Koffman, MD, MPH, Board Chair, is a retired military medical officer with over 30 years of active service in the United States Navy. He left active duty in 2015 to pursue additional training in integrative medical modalities. This interest in mind-body medicine was piqued by his terminal military assignment as the Clinical Chief at the National Intrepid Center of Excellence (NICoE) for Psychological Health and Traumatic Brain Injury. Following retirement, he earned a CIIS Certificate in Psychedelic-Assisted Therapies and Research in 2020. Robert conducts research in the management of PTSD with alternative medicines and integrative modalities as a Red Cross provider (psychiatrist). He cares for wounded warriors at the NICoE and works as a volunteer researcher at the Aquilino Cancer Center (located aboard the Shadygrove Adventists Hospital in Rockville, MD) for Treatment Resistant Depression with Psilocybin. Additionally. He will be working with FDA-approved, MAPS-sponsored Expanded Access trials in MDMA-Assisted Therapy for PTSD.
Amy Emerson, BSMAPS Public Benefit Corporation
Amy Emerson is the Chief Executive Officer at the MAPS Public Benefit Corporation (MAPS PBC), a wholly owned subsidiary of the Multidisciplinary Association for Psychedelic Studies (MAPS). As the Chief Executive Officer, Amy has led the growth and development of MAPS and is responsible for overall global regulatory strategy and implementation of research programs with a focus on the MDMA-assisted psychotherapy program within MAPS PBC. Amy brings decades of pharmaceutical development and research experience in Phase 1 through Phase 3 Randomized Controlled Trials, including supporting three successful regulatory approvals for new biologics. Her professional experience at Novartis, Chiron, and other pharmaceutical companies (1993-2009) spans various fields including immunology, oncology, and vaccines.
Benjamin Kelmendi, MDYale University
Benjamin (Ben) Kelmendi, MD, is an assistant professor at Yale University, and has been involved in psilocybin research for several years. He has an impressive list of awards, including a recently received a K23 award from the National Institutes of Health. He was supported by the Heffter Research Institute for his study of the use of psilocybin-assisted therapy for the treatment of obsessive compulsive disorder (OCD), an ongoing clinical study. Ben has been a mentor in the CIIS Certificate Program in Psychedelic-Assisted Therapies and Research. He is deeply committed to legitimizing and accrediting the process of bringing psychedelic medicine into mainstream psychiatry.
Diana Quinn, NDPsychedelic Liberation Collective
Diana Quinn, ND, is a queer Chicana and licensed naturopathic doctor with over fifteen years of clinical experience in integrative mental health with a focus on trauma, somatics and mind-body medicine. Her work is grounded in healing justice, a framework that aims to intervene on generational trauma and bring collective practices to transform the consequences of oppression. She is dedicated to building equity, accessibility and structural competency in the field of psychedelics. She is a co-founder of the Psychedelic Liberation Collective, offering community care, anti-racism resources, and monthly integration circles for Black, Indigenous and people of color and the 2SLGBTQIA+ community. Dr. Quinn has recently completed training in the California Institute for Integral Studies Psychedelic-Assisted Therapies and Research program and is a member of Chacruna’s Racial Equity and Access Committee. She sits on boards and advisory committees for multiple organizations and initiatives focused on justice, equity, diversity and access (JEDI).
Janis Phelps PhDCalifornia Institute of Integral Studies
Janis Phelps, PhD, is a leader in the field as the Director of the California Institute of Integral Studies’ Center for Psychedelic Therapies and Research. As the Center’s founder, Dr. Phelps developed and launched the first university accredited, post-graduate training program for psychedelic therapy and research. She held the position of the Dean of Faculty of the six doctoral departments in the CIIS School of Humanities and Social Sciences. Phelps is a board member of the Heffter Research Institute, which has conducted highly influential psilocybin-assisted psychotherapy research since the 1990’s. Her 2018 journal publication, Developing Guidelines and Competencies for the Training of Psychedelic Therapists, describes best practices in the academic training of medical and mental health professionals in this field. These ideas are further developed in a 2019 chapter on “Training Psychedelic Therapists” in Advances in Psychedelic Medicine, edited by Michael Winkelman and Ben Sessa. A licensed clinical psychologist, she is a key contributor to the creation of a national certification board for psychedelic therapists. She is a consultant on methods of scaling effective training programs to meet the burgeoning need for well trained mental health and medical professionals in the field of psychedelic medicine. Dr. Phelps maintains a private clinical practice in Mill Valley, CA.
Sara Reed, MS, LMFTMind's iHealth Solutions
Sara Reed, MS, LMFT, is an empathic leader, mental health futurist, and clinical researcher, Sara examines the ways culture informs the way we diagnose and treat mental illness. She is a Licensed Marriage and Family Therapist and the CEO of Mind's iHealth Solutions, a digital health company that provides evidence based and culturally responsible mental health services for underserved groups. She supervises and trains clinicians in providing culturally responsible mental health treatment. Sara's prior research work includes participating as a Study Therapist on the Psilocybin-Assisted Therapy research study for Major Depression at Yale University. Before joining the research team at Yale, Sara was a SubInvestigator and Study Coordinator for the Multidisciplinary Association for Psychedelic Studies (MAPS) Phase 2 MDMA Clinical Study of Posttraumatic Stress Disorder (PTSD). Sara is also an Advisor for Journey Colab and a former member of Chacruna's Racial Equity and Access Committee.
Robert Strayhan, MD
Robert Strayhan, MD, is a physician specializing in psychiatry. He has had a lifelong interest in cross-cultural and transpersonal psychiatry. He is a 2020 graduate of the CIIS Certificate in Psychedelic-Assisted Therapies and Research Program. Robert has completed the Three-Year Program of Advanced Initiations in Shamanism and Shamanic Healing, as taught by Michael Harner, PhD. He is particularly interested in examining how the construct of race can influence the set and setting of psychedelic-assisted psychotherapy. He has personally benefited from the study of various meditation techniques and has been a practitioner of Systema (a Russian martial art), Tai Chi and Afro-centric martial arts.
Malynn Utzinger, MDUsona Institute
Malynn Utzinger, MD, Co-Founder and Director of Integrative Medicine at Usona Institute and Director of Integrative Practices at Promega Corporation, is a physician and teacher of practices for individual and collective wellbeing. Her work began in 1993 at the Preventive Medicine Research Institute in Sausalito, CA under the direction of lifestyle medicine pioneer Dean Ornish, MD. She completed an internship with Andrew Weil at the University of Arizona, and a research fellowship and preventive oncology at the University of Wisconsin, where she also established the university’s first course in Complementary and Alternative Medicine in 1997. After working for the University of Wisconsin and in private practice in Madison, she took the opportunity to become the Director of Women’s Health at Chopra Center in Carlsbad, CA and completed her certification as an ayurvedic master. She was the director of the nation’s first HMO-based complementary and alternative medicine program at GHC in Madison, WI and has been a wellness consultant and teacher in NYC and Connecticut for Eileen Fisher, Charym, Jois Yoga, and the Milford Hospital She continues to teach integrative medicine and practices for emotional and social intelligence at Promega, a wellness-oriented life sciences company headquartered in Madison, WI.
Monnica T. Williams, PhD, ABPPUniversity of Ottawa
Behavioral Wellness Clinic
Monnica T. Williams, PhD, is a board-certified licensed clinical psychologist and Associate Professor at the University of Ottawa, in the School of Psychology, where she is the Canada Research Chair in Mental Health Disparities. She is also the Clinical and Training Director of the Behavioral Wellness Clinic in Connecticut. Prior to her move to Canada, Dr. Williams was on the faculty of the University of Pennsylvania Medical School (2007-2011), the University of Louisville in Psychological and Brain Sciences (2011-2016), and the University of Connecticut (2016-2019) where she had appointments in both Psychological Science and Psychiatry. Dr. Williams' research focuses on BIPOC mental health, culture, psychometrics, and psychopathology, and she has published over 150 scientific articles on these topics. Current projects include the assessment of race-based trauma, barriers to treatment in OCD, improving cultural competence in the delivery of mental health care services, and interventions to reduce racism. This includes her work as a PI in a MAPS multisite study of MDMA-assisted psychotherapy for PTSD for people of color. She also gives diversity trainings internationally for clinical programs, scientific conferences, and community organizations. She has served as the African American SIG leader for Association of Behavioral and Cognitive Therapies (ABCT), and currently is Chair of their Academic Training & Education Standards (ATES). She also serves on the Accreditation Panel of the Canadian Psychological Association.
Scott Shannon, MDChief Executive Officer
Scott Shannon, MD, has been a student of consciousness since his honor’s thesis on that topic at the University of Arizona in the 1970s under the guidance of Andrew Weil. Following medical school, MDMA assisted psychotherapy became a facet of his practice before this medicine was scheduled in 1985. He completed a psychiatry residency at a Columbia program in New York followed by a fellowship in child/adolescent psychiatry in New Mexico. Scott has published four books on holistic and integrative mental health including the first textbook for this field in 2001. Scott is a past President of the American Holistic Medical Association and a past President of the American Board of Integrative Holistic Medicine. In these roles he was instrumental in achieving board certification for the specialty of integrative medicine. Scott serves as a site Principal Investigator and therapist for the Phase III trial of MDMA assisted psychotherapy for PTSD. Scott teaches for the Psychedelic Research and Training Institute (PRATI) training professionals in ketamine-assisted psychotherapy. He founded Wholeness Center, the largest integrative mental health center in the US, in 2010 with a group of aligned professionals to create innovation in collaborative mental health care. Scott believes that psychedelic medicine delivers the spiritual framework in the body-mind-spirit healing that our world is calling for.
Kirk MarckwaldInterim Executive Director
Kirk Marckwald is the Founder of CEA Consulting and has been at the helm as a Principal since 1984. His deep experience in energy and environmental regulation provides the foundation for CEA’s work with a variety of private and public sector clients. Kirk has led large-scale regulatory reform and strategic planning projects for major manufacturing and transportation companies as well as for trade associations and nonprofits. He has represented individual clients and trade associations before legislative and regulatory agencies in California and Washington, D.C. In July 1999, Governor Davis appointed Kirk as a public member of the California Board of Forestry, where he served as the Vice-Chair of the Board until 2007. Kirk currently serves as the Chairman of the Board of the Institute for Local Self Reliance and on the Boards of the Pacific Forest Trust, the Blue Mountain Center and the Point Reyes National Seashore Association.
Gina MagañaProgram Manager
Gina Magaña has over 10 years of experience as a Project Manager leading cross-functional teams in diverse expertise spanning herbal medicine, environmental consulting, legal services, non-profit administration, and public service. She is well-versed in project management methodologies, clinical intake and assessments, and organizational development and leadership. She holds a Bachelor of Arts in Anthropology from the University of Texas – Rio Grande Valley and is a recent graduate of the Holistic Pathway at Hill College. Mission driven, creative and a resourceful problem solver, she is known for cultivating strong relationships and partnerships. Gina supports the Board of Psychedelic Medicines and Therapies efforts in overseeing the development and achievement of the organization’s goals.
- Lia Mix, LMFT
- Janis Phelps, PhD
- Amy Emerson
- Robert Strayhan, MD
- Bob Jesse
- Scott Shannon, MD
Electors and Stakeholder Groups Represented
- Nicole Buchanan, PhD, Licensed Practitioner
- Susana Bustos, PhD, Traditional Practitioner
- Shannon Clark-Carlin, MA, MAPS
- Ricci Coddington & Patricia James, Traditional Practitioner
- Mary Cosimano, LCSW, Researcher
- Stan Grof, MD, Public Figure
- Maria Mangini, PhD, FNP, California Institute of Integral Studies
- Michael Mithoefer, MD & Annie Mithoefer, RN, Researchers
- David Nichols, PhD, Researcher
- Nicholas Powers, PhD, Public Figure
- Sylver Quevedo, MD, MPH, Licensed Practitioner
- Shawn Rubin, PsyD, Hefter
- Gita Vaid, MD, Ketamine Practitioner
- Andrew Weil, MD, Public Figure
Executive Director Job Description
The Board of Psychedelic Medicine and Therapies (BPMT) is a national certifying board for psychedelic practitioners working in a therapeutic setting and is sponsored by the Players Philanthropy Fund, a 501(c)(3) organization. With the increasing legalization and decriminalization of psychedelic medicine, there is a growing need to regulate such therapies to ensure safety and national accessibility. This Certification Board is a core component to provide licensed clinical practitioners with a legal pathway to administer and safely guide participants through psychedelic assisted therapy. Moreover, like its mission, the role of the BPMT is to ensure the competent, safe, and ethically delivered practice of psychedelic medicine, throughout its many multifaceted, culturally, and contemporaneously diverse applications, while assuring equitable access and availability for all.
The Executive Director (ED) will be responsible for managing and directing the launch of this new, national certification entity and they will help guide BPMT's critical role in developing this emerging field in mental health care. They, in concert with the Board, will build the organization to ensure that the proper processes, procedures, and practices are in place to certify professionals in the practice of psychedelic psychotherapy. The ED is responsible for overseeing all operations, strategic planning, and ensuring the growth and fiscal responsibility of the organization. It is the responsibility of the ED to further the mission and values of BPMT, and to hold strategic vision reflective of the roots of this work in collaboration with the Board of Directors.
- Lead a nimble team staffed to deliver a best-in-class, nationally respected and recognizedcertification program
- Guide all organizational activities and operations with a commitment to social justice, aligned with the principles of justice, equity, diversity, and inclusion (JEDI)
- Ensure that the organization is grounded in the sacred history of this work by Indigenous peoples and lineage holders of the field
- Implement policies & procedures that are preparatory for sustained growth
- Oversee key operational functions including human resources, finance, development, marketing, media relations, communications, board accreditation and certification processes
- Ensure organizational and certification records are properly maintained
- Manage business model development in accordance with Board and committees that will lead to being self-sustainable by 2025
- Guide fundraising activities by Board of Directors and industry partners
- Provide sound fiscal planning, prepare budgets, and monitor budget compliance
Marketing and Communications
- Develop and Implement marketing, communication, and collaboration strategies
- Cultivate and sustain long-term strategic relationships and partnerships with a variety of organizations including academic programs, agencies, professional associations, etc.
Board of Directors Support
- Support the Board in strategic planning
- Provide regular Board updates and necessary reporting
- Provide orientation and training for new Board of Directors
- Ensure Board nomination and selection process in compliance with established policies
Board Accreditation Activities
- Foster and implement policies required for the Board accreditation process
- Ensure the integrity of certification in maintaining ethical relationships within the industry andperceptive of conflict-of-interest issues
- Ensure effective certification program administration
- Provide oversight and continual monitoring for the certification program including administrativeand examination development and deliverables
- Minimum Bachelor’s degree in relevant field, Masters preferred
- Self-starter with a broad range of skills and an entrepreneurial spirit
- Demonstrate the ability of full range managerial, logistical, and supervisorial responsibilities
- Strong and artful communication and uncompromised integrity
- Demonstrate a firm understanding of intersectional social justice issues and implementation in organizational operations both internally and externally with a commitment to diversity, equality, and inclusion
- Six years minimum of progressive management, administrative, and/or leadership experience with a non-profit organization
With a demonstrated ability to:
- develop and implement organizational budget
- work effectively with board of directors
- develop new relationships with new donors and raise significant funds
- develop and manage strategic partnerships
- lead strategic planning process and implement successfully
- develop and implement organizational policies and procedures
- execute fundraising initiatives to help the organization meet financial goals
- craft and manage grant applications and fundraising proposals
- Experience with professional credentialing or developing high-stakes assessments
- Knowledge of psychedelic-assisted therapies
- Experience in writing grant proposals, fundraising appeals, and press materials
This is a remote position for the chosen applicant who is in the United States.
COMPENSATION & BENEFITS
This is a full-time exempt position. Annual salary range starts from $140,000 to $175,000, plus benefits and will be negotiated commensurate with experience. Changes in compensation package would be tied to organizational growth.
HOW TO APPLY
Please send a resume and cover letter as a single attachment to firstname.lastname@example.org. Subject: [Your First and Last Name] - Exec Dir Application.
In the body of the email, please answer the following questions:
- Did you review the compensation and are you comfortable with the range?
- When would you be able to start?
- What makes you uniquely qualified for this position?
- Do you have any experience working in or educating the public about misunderstood fields, ideas or emerging science? If so, give a specific example on how you handled criticism or misinformation.
- What inspired you to apply for this role?
- What is a recent article, book or movie you have seen that was thought provoking and why?
- How did you hear about this position?
EQUAL EMPLOYMENT OPPORTUNITY POLICY
The Board of Psychedelic Medicine and Therapies values diverse perspectives and life experiences. All qualified applicants will be considered regardless of race, color, ethnicity, creed, national origin, ancestry, gender, marital status, disability, religious or political affiliation, age, sexual orientation, gender identity, or protected veteran status.